Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Mi Wu

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Nature Communications|December 23, 2014
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genesSaravana M Dhanasekaran, O Alejandro Balbin, Guoan Chen, et al.
Nature Medicine|November 22, 2011
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancerDan R Robinson, Shanker Kalyana-Sundaram, Yi-Mi Wu, et al.
Science Translational Medicine|September 5, 2014
Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastasesXinhai Wan, Paul G Corn, Jun Yang, et al.
Cancer Discovery|November 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint BlockadeYi Bao, Gabriel Cruz, Yuping Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2024
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT TrialCharles B Nguyen, Melissa A Reimers, Chamila Perera, et al.
The Journal of Clinical Investigation|September 16, 2025
CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical modelsYi Bao, Yu Chang, Jean Ching-Yi Tien, et al.
Cancer Discovery|April 6, 2013
Identification of targetable FGFR gene fusions in diverse cancersYi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, et al.
JCO Precision Oncology|August 25, 2020
Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain TumorsCarl Koschmann, Yi-Mi Wu, Chandan Kumar-Sinha, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Nature Medicine|March 31, 2015
Targeting the MLL complex in castration-resistant prostate cancerRohit Malik, Amjad P Khan, Irfan A Asangani, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Nature Communications|December 23, 2014
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genesSaravana M Dhanasekaran, O Alejandro Balbin, Guoan Chen, et al.
Nature Medicine|November 22, 2011
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancerDan R Robinson, Shanker Kalyana-Sundaram, Yi-Mi Wu, et al.
Science Translational Medicine|September 5, 2014
Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastasesXinhai Wan, Paul G Corn, Jun Yang, et al.
Cancer Discovery|November 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint BlockadeYi Bao, Gabriel Cruz, Yuping Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2024
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT TrialCharles B Nguyen, Melissa A Reimers, Chamila Perera, et al.
The Journal of Clinical Investigation|September 16, 2025
CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical modelsYi Bao, Yu Chang, Jean Ching-Yi Tien, et al.
Cancer Discovery|April 6, 2013
Identification of targetable FGFR gene fusions in diverse cancersYi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, et al.
JCO Precision Oncology|August 25, 2020
Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain TumorsCarl Koschmann, Yi-Mi Wu, Chandan Kumar-Sinha, et al.
Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.
Nature Medicine|March 31, 2015
Targeting the MLL complex in castration-resistant prostate cancerRohit Malik, Amjad P Khan, Irfan A Asangani, et al.
Pageof 8